Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Electrophysiologic Studies of Cognition in Epilepsy Patients

NCT05769634
unknownnot_applicable

Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal

NCT05776745
completednot_applicable

Localizing the Epileptogenic Zone With High Resolution Electroencephalography

NCT01090934

Clinical Trials (3)

Showing 3 of 3 trials
NCT05769634Not Applicable

Electrophysiologic Studies of Cognition in Epilepsy Patients

Completed
NCT05776745Not Applicable

Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal

Unknown
NCT01090934Not Applicable

Localizing the Epileptogenic Zone With High Resolution Electroencephalography

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3